Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

2,996 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

An update on larynx cancer (2017, background): “It is worth noting, however, that there did seem to be a more significant beneficial effect on distant metastasis in the induction cohort.(78) A follow-up study examined this data set with respect to primary tumor site, and 3216 patients with laryngeal cancer were included.”
Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. (2010, result): “Similar results were found in head and neck cancers.(23) We found no difference in the effect of concomitant radiochemotherapy according to patients’ characteristics or to the type of chemotherapy used.”
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. (2013, background): “8% for concomitant treatment.(9) A phase III comparison of alternating PF and RT versus induction PF followed by RT for larynx and hypopharynx cancers postulating improved outcomes with the alternating regimen showed no difference in larynx preservation.”